News & Updates

Show Multimedia Only

Prenatal pelvic floor workout may prevent postpartum stress urinary incontinence

06 May 2026 by

Engaging in pelvic floor workout (PEFLOW) during pregnancy appears to reduce the risk of postpartum stress urinary incontinence (SUI), according to a study.

Prenatal pelvic floor workout may prevent postpartum stress urinary incontinence

06 May 2026

Plasma exchange helps enhance vision in patients with acute optic neuritis

06 May 2026

Plasma exchange (PLEX) appears to improve visual outcomes in acute optic neuritis (ON), reveals a study. Vision loss severity, older age, prior ON in the affected eye, and delay to PLEX tend to contribute to less visual recovery.

Plasma exchange helps enhance vision in patients with acute optic neuritis

06 May 2026

Enzalutamide plus leuprolide delays metastasis, progression in prostate cancer

06 May 2026 by

Prostate cancer patients treated with enzalutamide plus leuprolide have a higher probability of remaining free of distant metastasis, castration resistance, symptomatic progression, and first symptomatic skeletal event (SSE) at 5 years than those treated with leuprolide alone, as shown by the results of the EMBARK study.

Enzalutamide plus leuprolide delays metastasis, progression in prostate cancer

06 May 2026

Does semaglutide use raise NAION risk?

06 May 2026

Users of semaglutide do not appear to be at greater risk of developing nonarteritic anterior ischaemic optic neuropathy (NAION), suggests a study.

Does semaglutide use raise NAION risk?

06 May 2026

Does anaesthetic technique affect cancer surgery outcomes?

06 May 2026 by

Propofol-based anaesthesia does not improve cancer-related outcomes in patients undergoing surgical resection of malignancies in the GA-CARES* trial.

Does anaesthetic technique affect cancer surgery outcomes?

06 May 2026

Novel benzamide antipsychotic turns in good efficacy, safety results in phase 2 trial

06 May 2026

The investigational benzamide LB-102 (N-methyl amisulpride) is well tolerated and helps reduce symptoms in patients with schizophrenia experiencing an acute episode, according to the results of the NOVA1 phase 2 trial.

Novel benzamide antipsychotic turns in good efficacy, safety results in phase 2 trial

06 May 2026

Camrelizumab plus chemo sets new benchmark in NPC

06 May 2026 by

A secondary analysis of the phase III CAPTAIN-1st trial shows a significant overall survival (OS) benefit when camrelizumab is added to gemcitabine and cisplatin (GC) for the first-line (1L) treatment of recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).

Camrelizumab plus chemo sets new benchmark in NPC

06 May 2026

First HK consensus statement on use of Alzheimer’s disease biomarkers and anti-amyloid therapies

06 May 2026 by

In response to increasing need for accurate diagnosis of Alzheimer’s disease (AD) pathology with the availability of anti-amyloid therapies (AATs), a 20-member expert panel in Hong Kong has formulated the first multispecialty consensus recommendations to provide practical locally-tailored guidance for healthcare practitioners on the use of imaging and biomarkers for AD diagnosis and AATs.

First HK consensus statement on use of Alzheimer’s disease biomarkers and anti-amyloid therapies

06 May 2026

Severe malarial anaemia & cerebral malaria in children linked to lasting cognitive and academic deficits

06 May 2026 by

Survivors of early-childhood cerebral malaria or severe malarial anaemia may experience persistent deficits in overall cognitive ability and mathematics achievement up to 15 years after the acute episode, an African study has found.

Severe malarial anaemia & cerebral malaria in children linked to lasting cognitive and academic deficits

06 May 2026

Weight-loss outcomes in Asians with high BMI better with cagrilintide–semaglutide vs semaglutide

05 May 2026 by

Individuals with overweight or obesity in East Asia shed more weight following treatment with the fixed-dose combination of cagrilintide plus semaglutide than with semaglutide alone, as shown in the phase 3a REDEFINE 5 trial.

Weight-loss outcomes in Asians with high BMI better with cagrilintide–semaglutide vs semaglutide

05 May 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Prenatal pelvic floor workout may prevent postpartum stress urinary incontinence

Prenatal pelvic floor workout may prevent postpartum stress urinary incontinence

Plasma exchange helps enhance vision in patients with acute optic neuritis

Plasma exchange helps enhance vision in patients with acute optic neuritis

Enzalutamide plus leuprolide delays metastasis, progression in prostate cancer

Enzalutamide plus leuprolide delays metastasis, progression in prostate cancer

Does semaglutide use raise NAION risk?

Does semaglutide use raise NAION risk?

Does anaesthetic technique affect cancer surgery outcomes?

Does anaesthetic technique affect cancer surgery outcomes?

Novel benzamide antipsychotic turns in good efficacy, safety results in phase 2 trial

Novel benzamide antipsychotic turns in good efficacy, safety results in phase 2 trial

Camrelizumab plus chemo sets new benchmark in NPC

Camrelizumab plus chemo sets new benchmark in NPC

First HK consensus statement on use of Alzheimer’s disease biomarkers and anti-amyloid therapies

First HK consensus statement on use of Alzheimer’s disease biomarkers and anti-amyloid therapies

Severe malarial anaemia & cerebral malaria in children linked to lasting cognitive and academic deficits

Severe malarial anaemia & cerebral malaria in children linked to lasting cognitive and academic deficits

Weight-loss outcomes in Asians with high BMI better with cagrilintide–semaglutide vs semaglutide

Weight-loss outcomes in Asians with high BMI better with cagrilintide–semaglutide vs semaglutide